Updates and Events

Winning projects will explore new potential treatment approaches to prevent lupus from developing or prevent or slow disease progression. New York, NY, April 20, 2023. The Lupus Research Alliance (LRA) today announced the newest Lupus Mechanisms and Targets Award grant recipients. The winning four projects collectively test potential treatment approaches to prevent lupus from developing […] READ MORE

Lupus Accelerating Breakthroughs Consortium to address challenges impacting lupus trial success and to accelerate treatment breakthroughs  Washington, DC, March 29, 2023 – The Lupus Research Alliance (LRA) today announced the Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a first-of-its-kind public-private partnership bringing people with lupus together in collaboration with the U.S. Food and Drug Administration (FDA), […] READ MORE

March 27, 2023 Based on positive results of a Phase 2 clinical trial testing upadacitinib (Rinvoq®) given alone or with elsubrutinib once daily for moderate to severe systemic lupus erythematosus, developer AbbVie is advancing the drug to a Phase 3 trial. The trial also showed that steroid dose either went down or stayed the same […] READ MORE

During 2023 Brain Awareness Week, it’s important to bring attention to how lupus affects this vital organ.  We know that lupus can cause symptoms that include depression, brain fog, and headaches, as well as cognitive issues with memory and ability to think clearly.  Yet our understanding of how and why lupus impacts the brain is […] READ MORE

New York, NY, March 23, 2023. The Lupus Research Alliance (LRA) today announced the recipients of the newest Lupus Innovation Award (LIA) grants. Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple components of lupus, focusing on its causes and the development of more personalized approaches to lupus treatments. […] READ MORE

March 8, 2023 As part of our researcher interview series, we are featuring 3 Questions with Ashira Blazer, MD, at Hospital for Special Surgery — one of our Diversity in Lupus Research Award recipients. Below Dr. Blazer explains why she focused her career on lupus, and explains how the project LRA is funding will help […] READ MORE

March 8, 2024 Our Team Life Without Lupus® will once again join the 50,000+ runners in the TCS New York City Marathon Sunday November 3, 2024 running the 26.2 mile course of this iconic international event. Have you or someone you know imagined running a marathon? This year, run for Team Life Without Lupus® to […] READ MORE

February 28, 2023 The Lupus Research Program (LRP) within the Department of Defense that you, our community, advocated to create, has recommended to fund 12 new applications for promising scientific studies to improve treatment for lupus. The dedicated Lupus Research Program was first established in 2017 under the Congressionally Directed Medical Research Programs operated by […] READ MORE

Feb. 22, 2023 The Lupus Research Alliance has funded some of the biggest breakthroughs in lupus research, and we’re pleased to share a new series on the scientists that help make that possible.  The LRA’s Diversity in Lupus Research Awards aim to address underrepresentation of minorities in the scientific research profession.    As part of our […] READ MORE

February 3, 2023 This month, we celebrate lupus warrior Kaamilah Gilyard who is determined to change the lives of future generations by working hard to ensure equal representation of African Americans in lupus clinical studies. Having suffered greatly as a teenager to get a diagnosis of her lupus symptoms, Kaamilah is determined that today’s teens […] READ MORE

January 27, 2023 At 23, Kerry Harrington is running the NYC Half Marathon with LRA’s Team Life Without Lupus for two reasons – to prove to herself that she can despite her recent lupus diagnosis, and to contribute to a charity she believes in. For months, Kerry fought for a diagnosis. Symptoms including rashes, hair […] READ MORE

NEW YORK, NY. January 17, 2023— The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to lead Lupus Therapeutics (LT), the organization’s clinical research affiliate. An accomplished research scientist and organizational leader, Dr. Bell comes to Lupus Therapeutics with more than 25 years of […] READ MORE